Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Ambrilia Biopharma and Merck & Co. in license negotiation

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Confidential Client

Member of the license negotiation team (clinical phase 1) between Ambrilia Biopharma Inc. and Merck & Co. (reported value: $232,000,000)

Team

    Subscribe

    Receive email updates from our team

    Subscribe